DRNA - Dicerna Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4244
Avg. Estimate-0.65-0.81-2.94-3.11
Low Estimate-0.8-0.87-3.03-3.75
High Estimate-0.28-0.75-2.88-2.59
Year Ago EPS-0.68-0.68-2.87-2.94
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3134
Avg. Estimate800k2M1.66M5.63M
Low EstimateN/A2M860kN/A
High Estimate2M2M2.9M10M
Year Ago Sales133k133k295k1.66M
Sales Growth (year/est)501.50%1,403.80%462.70%239.20%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.73-0.7-0.6-0.69
EPS Actual-0.68-0.68-1.15-0.92
Difference0.050.02-0.55-0.23
Surprise %6.80%2.90%-91.70%-33.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.65-0.81-2.94-3.11
7 Days Ago-0.69-0.96-2.7-2.76
30 Days Ago-0.69-0.96-2.7-2.76
60 Days Ago-0.69-0.96-2.7-2.76
90 Days Ago-0.7-0.96-2.73-2.59
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 Days1111
Up Last 30 Days2142
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesDRNAIndustrySectorS&P 500
Current Qtr.4.40%N/AN/A0.26
Next Qtr.-19.10%N/AN/A0.27
Current Year-2.40%N/AN/A0.08
Next Year-5.80%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A